Home/Filings/4/0001144204-16-101701
4//SEC Filing

Alliqua BioMedical, Inc. 4

Accession 0001144204-16-101701

CIK 0001054274operating

Filed

May 12, 8:00 PM ET

Accepted

May 13, 2:58 PM ET

Size

5.5 KB

Accession

0001144204-16-101701

Insider Transaction Report

Form 4
Period: 2016-05-11
POSNER BRIAN M
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2016-05-11+100,000241,539 total
Footnotes (1)
  • [F1]Represents a restricted stock award that is subject to forfeiture until vested. The award vests in three equal installments based on the Issuer's satisfaction of certain performance criteria prior to May 11, 2021, with one-third (1/3) of the awarded shares vesting on each date, if any, that the Issuer files a report with the SEC reporting audited annual gross revenues that equal or exceed each of $25 million, $30 million and $36 million, subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the reporting person, effective as of May 11, 2016.

Issuer

Alliqua BioMedical, Inc.

CIK 0001054274

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001054274

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 2:58 PM ET
Size
5.5 KB